U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06820255) titled 'DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer.' on Feb. 06.
Brief Summary: This study aims to prospectively observe whether certain alterations in some genes related to the DNA repair mechanism are related to better response to platinum-based chemotherapy used to treat metastatic bladder or urothelial cancers.
Study Start Date: Jan. 07
Study Type: INTERVENTIONAL
Condition:
Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable
Upper Tract Urothelial Cancer
Intervention:
DRUG: Platinum + Gemcitabine
Eligible patients will be treated with platinum-based chemoth...